Authors


Lucia Ricciardi, MD, PhD

Latest:

Multifaceted Approach to Managing Neuropsychiatric Symptoms of Parkinson Disease: Lucia Ricciardi, MD, PhD

The consultant neurologist and senior lecturer at St. Georges Hospital in London, explores the origins of common neuropsychiatric symptoms experienced by patients with Parkinson disease and how they may be exasperated. [WATCH TIME: 4 minutes]


Emilio Portaccio, MD

Latest:

Improving MS Management Through Early Intervention and Precision Medicine: Emilio Portaccio, MD

The professor of neurology at University of Florence talked about how early intervention, broader assessment tools, and personalized approaches are essential for effectively managing multiple sclerosis. [WATCH TIME: 4 minutes]


Noah Stansfield

Latest:

What to Expect at MDA’s 2025 Clinical and Scientific Conference: Barry J. Byrne, MD, PhD

The chief medical advisor at the Muscular Dystrophy Association shared key highlights of what attendees can expect at the 2025 MDA Clinical and Scientific Conference. [WATCH TIME: 4 minutes]


Jihan A. Grant, MD

Latest:

Search for Targeted Therapies for Primary Headaches Beyond Migraine: Jihan A. Grant, MD

The director of headache medicine at The Mount Sinai Hospital talked about the often-overlooked realm of primary headaches beyond migraines as well as the importance of developing targeted treatments and increasing understanding of their pathophysiology. [WATCH TIME: 7 minutes]


Katherine Turk, MD

Latest:

Improving Diagnosis, Screening Patients More Efficiently in Alzheimer Disease: Katherine Turk, MD

The behavioral neurologist at VA Boston Healthcare System talked about screening patients for mild cognitive impairment to improve diagnosis in Alzheimer disease at the 2023 AAN Annual Meeting. [WATCH TIME: 5 minutes]


Aaron Miller, MD, FAAN

Latest:

Practice Pearls for Management of NMOSD

Experts in neurology discuss immune tolerance as an alternative strategy and share practice pearls for approaching treatment of NMOSD.


Bradley McDaniels, PhD, CRC

Latest:

Tools for Cultivating Meaning This Holiday Season

What excites you? What awakens your sense of purpose? What gives your life meaning? Bradley McDaniels, PhD, CRC, explores the importance of meaning in one's life.


Gabriele C. De Luca, MD, DPhil, FRCPath, FAAN

Latest:

AUPN Leadership Minute Episode 28: Leadership to Effect Change

Episode 28 of the AUPN Leadership Minute features Donald S. Higgins, MD, of the VHA; and Gabriele C. De Luca, MD, DPhil, FRCPath, FAAN, of University of Oxford. [WATCH TIME: 5 minutes]


Annette Okai, MD, FAAN

Latest:

Getting Up to Speed on the Evolving Landscape of Multiple Sclerosis: Annette Okai, MD

The medical director of the North Texas Institute of Neurology and Headache offered an overview of the State of the Science Summit that was held on July 21, 2022, with a variety of expert clinicians in MS care. [WATCH TIME: 3 minutes]


Fiona Gupta, MD

Latest:

Dyskinesia: Importance of Giving Patients More Good “On- Time" In Parkinson’s Disease

Drs Isaacson, Pahwa, and Gupta discuss the management of dyskinesia and providing good ON time in Parkinson’s disease, sharing practical tips for early identification and treatment of dyskinesia, as well as their experience with current treatments.


Yuebing Li, MD, PhD

Latest:

Efficacy and Safety of Weekly Subcutaneous Efgartigimod for Myasthenia Gravis: Yuebing Li, MD, PhD

The neuromuscular neurologist at the Cleveland Clinic discussed findings from an analysis presented at AANEM 2023 that investigated the safety and efficacy of subcutaneous efgartigimod in patients with myasthenia gravis. [WATCH TIME: 5 minutes]


Garth T. Whiteside, PhD

Latest:

Sleep Disturbances and Recovering From Alcohol Use Disorder: Garth T. Whiteside, PhD

The head of preclinical development at Imbrium Therapeutics provided an overview of positive safe and efficacy findings from the phase 2 study investigating sunobinop. [WATCH TIME: 4 minutes]


Eric Leuthardt, MD

Latest:

Streamlining Stroke Rehab Systems in Common Clinical Care: Eric Leuthardt, MD

The founder and chief scientific officer of Neurolutions discussed complexities within the system to integrate new stroke rehab devices.


Brian Nagle, MD

Latest:

Promising Disease-Modifying Therapies in Parkinson Disease

Despite years of use of gold-standard therapy levodopa, therapeutic development in Parkinson disease has advanced rapidly and expanded to numerous novel pathways and targets.


Sube Banerjee, MD, MSc, MBA, FRCPysch

Latest:

Reimaging the Approach to Treating Alzheimer Agitation: Sube Banerjee, MD, MSc, MBA, FRCPsych

The professor of dementia and executive dean of the Faculty of Health at the University of Plymouth provided perspective on the way to attack Alzheimer agitation and why drug solutions often fall short. [WATCH TIME: 3 minutes]


Vikram Bhise, MD

Latest:

Talking Transitional Readiness for Teens With Multiple Sclerosis: Vikram Bhise, MD

The associate professor of pediatrics and neurology at Rutgers–Robert Wood Johnson Medical School commented on the need to recognize when adolescent patients are ready to learn more about their condition. [WATCH TIME: 5 minutes]


Alexandra Nelson, MD, PhD

Latest:

AUPN Leadership Minute Episode 39: Supporting K Awardees

Episode 39 of the AUPN Leadership Minute features Donald S. Higgins Jr, MD, of Veterans Health Administration, Albany Medical College; and Alexandra Nelson, MD, PhD, of the University of California San Francisco. [WATCH TIME: 5 minutes]


Sharon L. Rogers, PhD

Latest:

The Complexities of Alzheimer Disease Treatment and Diagnosis in Clinical Trials: Sharon L. Rogers, PhD

The chief executive officer at AmyriAD Therapeutics discussed the limitations of clinical trials assessing potential disease-modifying therapies for Alzhiemer disease including the lack of a diverse patient population and nonthorough clinical assessments for diagnosis. [WATCH TIME: 6 minutes]


Mony de Leon, EdD

Latest:

Insights Into Nasal Pathways for Brain Protein Sampling and Treatment Delivery: Mony de Leon, EdD

The director of the Brain Health Imaging Institute in the department of radiology at Weill Cornell Medicine talked about exploring nasal pathways as an alternative for brain protein sampling and drug delivery. [WATCH TIME: 4 minutes]


Shamik Bhattacharyya, MD

Latest:

Rethinking Treatment Strategies in NMOSD Based on Safety Failures and Emerging Therapies: Shamik Bhattacharyya, MD

The associate professor of neurology at Harvard Medical School talked about reconsidering therapy switches for NMOSD, incorporating safety failures like recurrent infections, and prioritizing real-world studies to validate findings. [WATCH TIME: 5 minutes]


Li Gan, PhD

Latest:

Sex-Based Genetic Risk and Immune Response Differences in Alzheimer Disease: Li Gan, PhD

The director of the Helen and Robert Appel Alzheimer’s Disease Research Institute at Weill Cornell Medicine talked about findings from a recently published study on immune responses to Alzheimer disease risk genes between male and female mice. [WATCH TIME: 4 minutes]


Jess Holguin, OTD, OT/L

Latest:

Ongoing Challenges for Neuromuscular and Movement Occupational Therapy: Jess Holguin, OTD, OT/L

Commenting on recent advances and persistent challenges for these patients, the associate professor of clinical occupational therapy at USC Keck Hospital spoke on the need to increase equity and access to care. [WATCH TIME: 6 minutes]


Ashkan Shoamanesh, MD

Latest:

Secondary Analyses of ANNEXA-I Trial Assessing Andexanet Alfa in Intracranial Hemorrhage: Ashkan Shoamanesh, MD

The associate professor of neurology at McMaster University talked about findings from secondary analyses on the phase 4 ANNEXA-I trial assessing andexanet alfa in patients with acute intracerebral hemorrhage. [WATCH TIME: 10 minutes]


Paula Barreras, MD

Latest:

Overcoming Language Barriers During the Diagnostic Process of Rare Neuroimmune Disorders: Paula Barreras, MD

The physician neurologist and neuroimmunologist at Cedars Sinai Medical Center detailed the difficulties with discussing neuroimmune disorders with newly diagnosed patients, including those who may not speak English. [WATCH TIME: 3 minutes]


Jennifer Martin, PhD

Latest:

The Case for Permanent Standard Time: Clinical and Public Health Implications

Experts in sleep medicine discuss the detrimental effects of daylight saving time on sleep, health, and public safety, advocating for the adoption of permanent standard time. [WATCH TIME: 5 minutes]


Jill Morris, PhD

Latest:

Global Impacts of Rare Disease Day for Patients With Neurologic Disorders: Jill Morris, PhD

The program director in the division of Neuroscience at the National Institute of Neurological Disorders and Stroke provided context on the importance of Rare Disease Day and strides made over the years. [WATCH TIME: 5 minutes]


Kristin Guilliams, MD, MSCI

Latest:

Importance of Identifying Etiology in Pediatric Stroke: Kristin Guilliams, MD, MSCI

The associate professor at Washington University School of Medicine provided commentary on the state of care for pediatric stroke, and the challenges with identifying the most likely etiology. [WATCH 3 minutes]



Anna Underhill, BS

Latest:

Overcoming the Complexities With Gene Therapy in ALS: Anna Underhill, BS

The postdoctoral researcher at King’s College London provided background on why gene therapies have not seen as much success in treating ALS, and the need for additional validation of genetic mutations. [WATCH TIME: 3 minutes]


Andrea Quattrone, PhD

Latest:

Andrea Quattrone, MD: The Importance of Early Differentiation Between PSP and Parkinson

The neurology resident at Magna Graecia University of Catanzaro also touched on how accurate early diagnoses can help hone clinical trial recruitment.

© 2025 MJH Life Sciences

All rights reserved.